Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Most other NCEs under investigation follow traditional therapeutic avenues explored for uterine fibroids, which signals limited innovation: there are three GnRH antagonists, including merigolix (Phase II), and a selective progesterone receptor antagonist, telapristone, currently investigated in a Phase II study as a vaginal insert (both also investigated for endometriosis-related pain)
These products exist in a zone of scientific uncertainty
Storage instructions: Store in a cool, dry place
They bind to GLP-1 receptors throughout the body and produce a prolonged version of the natural response, dramatically reducing hunger, improving insulin sensitivity, and driving significant weight loss
.png.jpg)
US$ 23.96
US$ 28.25
US$ 27.53
